Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-007317
Filing Date
2023-02-06
Accepted
2023-02-06 16:47:26
Documents
1
Period of Report
2023-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4025
  Complete submission text file 0001209191-23-007317.txt   5512
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Issuer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STRUCTURE THERAPEUTICS INC. 611 GATEWAY BLVD, SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address
Yoon Jun (Reporting) CIK: 0001962414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41608 | Film No.: 23591279